SEC Form D · Amendment · filed December 11, 2019
RedShift BioAnalytics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (17)
William Cadogan · Burlington, MADirectorBryson Holliman · Burlington, MADirectorEugene Ma · Burlington, MAExecFrank Smith · Burlington, MADirectorCharles Marshall · Burlington, MAExec · DirectorKathleen A. Pecard · Brookfield, WIDirectorStephen W. Farr · San Ramon, CADirectorChristopher C. Cox · Lansing, MIExecCarl C. Riedy · Washington, Washington, D.C.Exec · DirectorCatherine A. Cawthon · Dublin, OHDirectorRob Carson · Burlington, MADirectorKimberly A. Arntson · Vancouver, British Columbia, CanadaExec · DirectorKeith W. Bank · San Ramon, CADirectorFelix D. Navarro-Grau Hurtado · Vancouver, British Columbia, CanadaExecJoshua Pierce · San Francisco, CADirectorDaniel B. Stein · Fayetteville, ARDirectorRob Carson · Burlington, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗